Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy Volunteers

Clinical trial NCT00813774 · COMPLETED

Trial details

NCT number: NCT00813774
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability Study on Healthy Volunteers

Start date: 2008-02-01
Primary completion: 2008-07-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.